Navigation Links
NeurogesX to Present at Two February Investor Conferences
Date:2/8/2011

pain associated with neuropathic pain conditions. Since its inception, NeurogesX has leveraged its passion to help people with pain to efficiently develop this concept, resulting in the commercial launch of Qutenza® (capsaicin) 8% patch in 2010. The Company continues to apply its knowledge and expertise in the development of other novel treatments for pain.

The Company's lead product, Qutenza, is a localized dermal delivery system containing prescription strength capsaicin that is currently approved in the United States and the European Union. Qutenza is now available in the United States for the management of neuropathic pain associated with postherpetic neuralgia (PHN). In Europe, Qutenza is being marketed by Astellas Pharma Europe Ltd. (Astellas), the European subsidiary of Tokyo-based Astellas Pharma Inc., for the treatment of peripheral neuropathic pain in non-diabetic adults, either alone or in combination with other medicinal products for pain.

The Company is currently preparing to submit a supplemental new drug application (sNDA) to expand the U.S. label for Qutenza for the management of pain due to  HIV-associated neuropathy (HIV-AN) also known as HIV-distal sensory neuropathy (HIV-DSP).

The Company's most advanced product candidate, NGX-1998, is a topically applied liquid formulation containing a high concentration of capsaicin designed to treat pain associated with neuropathic pain conditions such as PHN. NGX-1998 has completed three Phase 1 studies and patient dosing is underway in a Phase 2 clinical trial in PHN patients.

The Company's early-stage pipeline includes pre-clinical compounds which are prodrugs of acetaminophen and various opioids. The Company has evaluated certain of these compounds in vitro and in vivo.

Safe Harbor StatementThis press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the Act). NeurogesX disclaims
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
2. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
3. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
4. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
5. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
6. NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation
7. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
8. NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
9. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
10. NeurogesX to Present at JMP Securities Healthcare Focus Conference
11. NeurogesX to Hold Conference Call to Discuss Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading health ... several new IT value-added reseller (VAR) national contracts that ... goods and services at lower costs. These include manufacturer ... such as initiative assistance and ongoing IT consulting support. ...
(Date:1/15/2014)... plc (LSE: SHP, NASDAQ: SHPG ) announces that it ... the announced tender offer for all of the outstanding shares of ... the waiver, the transaction is no longer conditional on OFT approval, ... 2014 following the currently scheduled expiration time, subject to the satisfaction ...
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and ... be able to protect their most important business ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of the ... steadfastly remains one of the most litigious industry ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2
... SPRING HARBOR, N.Y., Sept. 1 The ASCO ... Advisory Committee (ODAC) recommendation that the breast cancer indication ... voting members, breast cancer specialists, oncologists in private practice, ... available online now at ASCOPost.com and appear in the ...
... According to Millennium Research Group (MRG), the global authority on ... continue to be used in a narrow set of indications ... grow at a much lower rate than previously expected.  With ... compared to the nonfusion market as a whole which is ...
Cached Medicine Technology:The ASCO Post Publishes Multiple Perspectives on Outcome of ODAC Meeting Regarding Bevacizumab in Advanced Breast Cancer 2The ASCO Post Publishes Multiple Perspectives on Outcome of ODAC Meeting Regarding Bevacizumab in Advanced Breast Cancer 3European Interspinous Process Decompression Device Market Will Grow Nominally at 1.2% over the Next Five Years 2European Interspinous Process Decompression Device Market Will Grow Nominally at 1.2% over the Next Five Years 3
(Date:4/24/2014)... April 24, 2014 Scientific research at UT ... heart can heal itself completely, whereas the adult heart ... today has revealed why the heart loses its incredible ... simple oxygen. , Yes, oxygen. It is ... to circulate oxygen-rich blood throughout the body. But at ...
(Date:4/24/2014)... patients before, during and after colorectal surgery cut hospital ... to researchers who led a study of the approach ... recovery, is easier on patients before surgery, doing away ... typically prescribed. After surgery, patients are encouraged to eat ... faster recoveries. , Among findings published in the May ...
(Date:4/24/2014)... terminology, and the relevance of palliation in advanced ... randomized controlled trials (RCTs). This is the result ... Quality and Efficiency in Health Care (IQWiG), which ... Together with external experts, IQWiG analysed studies on ... malignant melanoma, and pancreatic cancer. For this purpose, ...
(Date:4/24/2014)... team of researchers was the first in the world ... a tumour of the jaw. , Ameloblastoma is an ... treatment. Ameloblastoma is most often found in the posterior ... often resulting in tissue deficiencies in the jaws as ... therapy could reduce the need for surgery and the ...
(Date:4/24/2014)... the first flu pandemic in the 21st century. The ... than 50 people in the country. Since 2011 the ... seasons). , Infections with influenza pH1N1 virus vary ... has recommended Tamiflu for treatment of patients with severe ... that it targets viral proteins which mutate quickly and ...
Breaking Medicine News(10 mins):Health News:Oxygen diminishes the heart's ability to regenerate, researchers discover 2Health News:New approach for surgery patients cuts hospital stays and costs 2Health News:New approach for surgery patients cuts hospital stays and costs 3Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3
... little difference in chemotherapy treatment; some critics say that,s ... -- A 2003 overhaul of Medicare that changed the ... alter cancer patients, perceptions of their quality of care, ... that cancer patients are waiting the same amount of ...
... Va., Oct. 8 A good night,s sleep,is ... an estimated 70,million Americans complain of sleeplessness. This ... (ACA) is offering,advice to help consumers select comfortable ... and neck pain., "Americans spend one-third of ...
... Ohio to make quality and safety list, AKRON, Ohio, ... named a "Leapfrog Top Hospital" for 2007. The only,facility in ... the nation,to make the list, Summa received this designation based ... a rating system that,assesses hospital quality and safety. According ...
... Oct. 8 Beginning in October, Concentra,("Concentra" or the ... For What Ails,You. This new theme is at the ... centers to various communities in the coming,year, beginning with ... area. The For What Ails You campaign is ...
... Oct. 8, 2007 /PRNewswire-FirstCall/,-- Although rising health ... America,s,local governments, most jurisdictions do not offer ... top health issues, according to,a survey of ... premier local,government leadership and management organization, and ...
... to Hear ... from Top Experts, SAN JOSE, Calif., ... Idiopathic Pulmonary Fibrosis (IPF),is the limitation the disease places on their ability ... that,obstacle for these patients by allowing them to "attend" a seminar,virtually and ...
Cached Medicine News:Health News:Medicare Changes Didn't Alter Cancer Care 2Health News:Medicare Changes Didn't Alter Cancer Care 3Health News:Medicare Changes Didn't Alter Cancer Care 4Health News:Proper Mattress Can Improve Sleep Comfort, Reduce Pain, Says American Chiropractic Association 2Health News:Proper Mattress Can Improve Sleep Comfort, Reduce Pain, Says American Chiropractic Association 3Health News:Summa Health System's Akron City Hospital Named 'Leapfrog Top Hospital' for 2007 2Health News:Concentra Offers a Cure 'For What Ails You' 2Health News:ICMA/CIGNA Survey: U.S. Cities and Counties Begin to Focus on Health Risks and Costs 2Health News:ICMA/CIGNA Survey: U.S. Cities and Counties Begin to Focus on Health Risks and Costs 3Health News:ICMA/CIGNA Survey: U.S. Cities and Counties Begin to Focus on Health Risks and Costs 4Health News:CPF 'Living with IPF' Patient Seminar to be Webcast Live October 13, 2007 2Health News:CPF 'Living with IPF' Patient Seminar to be Webcast Live October 13, 2007 3
... the storage of blood plasma in full ... attention to operating temperatures and performance means ... Standard freezer you will minimise bag cracking ... temperature an additional benefit is reduced thawing ...
Helmer offers Plasma Storage Freezer lines, the i.Series ipf 125-8. It is Designed to complement Blood Bank Refrigerators, it freezers offer outstanding features, including programmable defrost tim...
... PillCam SB Capsule Endoscope is a ... the gastrointestinal tract. Natural peristalsis moves ... painlessly throughout the gastrointestinal tract, transmitting ... The procedure is ambulatory, allowing patients ...
... 1400 Series Biosafety Cabinets ... revolutionize working in a ... most comfortable, quiet, and ... cabinet on the market, ...
Medicine Products: